3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
4
Seizures
3
Lennox Gastaut Syndrome
3
Epilepsies, Myoclonic
3
Anxiety Disorders
2
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Prostatic Neoplasms
1
Parasomnias
1
Pain
1
Neoplasms
1
Nausea
1
Marijuana Abuse
1
Liver Cirrhosis
1
Glioblastoma
1
Epilepsy
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chemotherapy-Induced Peripheral Neuropathy
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Pain
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Behavior
1
Interventions
Acetaminophen
4
Surveys and Questionnaires
3
Saline Solution
3
nabiximols
2
Standard of Care
2
Radiofrequency Ablation
2
Oxycodone
2
Music Therapy
2
Morphine
2
Methods
2
Electroacupuncture
2
Dronabinol
2
siltuximab
1
pegfilgrastim
1
oxycodone-acetaminophen
1
erenumab
1
Yoga
1
Xylitol
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Transcranial Direct Current Stimulation
1
Therapeutics
1
Telemedicine
1
STAMP-I protocol
1
Remifentanil
1
Range of Motion, Articular
1
Psychiatric Rehabilitation
1
Preoperative Exercise
1
Physical Therapy Modalities
1
Pentoxifylline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Cannabidiol
×
1 year
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled